RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Assessment of denosumab in Korean postmenopausal women with osteoporosis: randomized, double-blind, placebo-controlled trial with open-label extension

Assessment of denosumab in Korean postmenopausal women with osteoporosis: randomized, double-blind, placebo-controlled trial with open-label extension

Add to Collection
RCTs JM Koh, DJ Chung, YS Chung, MI Kang… - Yonsei Medical …, 2016 - synapse.koreamed.org

Chapter : Section13, Section25
Journal Year : 2016
Cited by : 22

… It is estimated that 35.5% of women 50 years of age or older … the placebo group would provide 99% power to detect a 3.5% … multicenter study in 250 Indian postmenopausal women with …..... Read More

Keywords : ['osteoporosis randomize doubleblind placebocontrolle trial', 'korean postmenopausal woman', 'openlabel extension', 'denosumab', 'assessment']
PubMed Link : https://synapse.koreamed.org/upload/synapsedata/pdfdata/0069ymj/ymj-57-905.pdf
Google Scholar Link : https://scholar.google.com/scholar?cites=16544336435985655992&as_sdt=2005&sciodt=0,5&hl=en&num=20